Oxford Nanopore Technologies
Begbroke Science Park
46 articles with Oxford Nanopore Technologies
Oxford Nanopore users have easy access to precise whole genome methylation detection from PCR-free nanopore sequencing using Remora.
At the annual London Calling conference, CTO Clive Brown and colleagues James Clarke, Stuart Reid, Lakmal Jayasinghe and Rosemary Sinclair Dokos have provided an Oxford Nanopore tech update summarising the status of its nanopore sensing platform, key recent developments that drive improved accuracy and increased output, and outlined the vision for future developments.
The annual London Calling genomics conference, hosted by Oxford Nanopore, starts , featuring more than 80 scientific talks across a range of disciplines, with thousands of scientists expected to attend either in person or online.
Oxford Nanopore sequencing technology is to be used by a group of researchers led by Evan Eichler, University of Washington and Danny Miller, University of Washington and Seattle Children's Hospital, to initially sequence 500 of the 1000 Genomes Project samples.
Oxford Nanopore has announced the next steps in its collaboration with Genomics England, which is using nanopore technology in an ongoing proof-of-concept project to evaluate the clinical and research applications of comprehensive genomic analysis of cancer tumours.
Nanopore sequencing enables the analysis of native DNA/RNA and sequencing of any length fragment from short to ultra-long, enabling the elucidation of all types of genetic and epigenetic variants.
Oxford Nanopore announces positive evaluation of new method for rapid drug-resistant tuberculosis profiling
Short Fragment Mode will be integrated into the operating software that drives nanopore devices, allowing sequencing of fragments as short as 20 bases on nanopore platforms.
A new DNA sequencing based test method developed by a team led by Ira Deveson, Head of Genomics Technologies at the Garvan Institute of Medical Research and collaborators, has been shown to screen for more than 50 genetic neurological and neuromuscular diseases.
Traditionally, rapid characterisation of variants that cause genetic disease, from whole human genome sequencing, has been challenging.
Highlights include release of new "Kit 12" and R10.4 flow cells for >Q20 raw read and around Q30 Duplex sequencing accuracy, and the new PromethION P2 device, a palm-sized, high-throughput sequencer that delivers the most accessible low-cost, high-output Oxford Nanopore sequencer
Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing
Oxford Nanopore announces multiple releases that expand and improve its sequencing technology offering in human genomics, at ASHG 2020.
LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19.
A new pre-print runs a head-to-head comparison between Loop Genomics, PacBio and Oxford Nanopore's accuracy in long read microbiome sequencing.
After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences in this litigation.
The gene sequencing industry has really taken off in the years since the Human Genome Project. Look at these best genome sequencing companies in the world.
Oxford Nanopore Announces That It Has Entered Into a Non-exclusive Agreement With Caribou Biosciences for CRISPR-Cas9 Enrichment for Nanopore Sequencing
Technology enables targeted sequencing for rapid, precise DNA analysis on portable or large sequencers
Oxford Nanopore has made Flongle starter packs available to purchase https://store.nanoporetech.com/flongle.html, after initial testing in an early-access programme.
New generation direct cDNA and PCR-cDNA 109 Kits provide full-length cDNA transcripts at high yields.
Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies today announced Amgen's equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology.